Welcome to Ir.ptcbio.com - Investors | PTC Therapeutics, Inc.

ir.ptcbio.com

Description: Ir PTC Bio. The Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential...

Google PR 4

Trustworthiness Good
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Good

Investors | PTC Therapeutics, Inc.

Ir.ptcbio.com: get to the top rated Ir PTC Bio pages and content popular with USA-based Ir.ptcbio.com users or check the following digest to find out more. Ir.ptcbio.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Ir.ptcbio.com team has yet to grow their social media activity, as the major social networks contain little or no materials related to this domain. Ir.ptcbio.com is hosted with Akamai Technologies, Inc. in United States. Ir PTC Bio traffic is not yet estimated by Alexa.

Visit ir.ptcbio.com

Domain info

Location:	United States
Registrant:	Domain Administrator (PTC Therapeutics)
Hosted by:	Akamai Technologies, Inc.
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	23.12.144.209

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

ptcbio.com

Whois

Expand

Ir.ptcbio.com popular pages to visit

Investors | PTC Therapeutics, Inc. The Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Investor FAQs | PTC Therapeutics, Inc. PTC Therapeutics trades on the NASDAQ Global Market and the stock ticker symbol is PTCT. Q. When was PTC Therapeutics' Initial Public Offering? PTC Therapeutics went public in June...

Press Releases | PTC Therapeutics, Inc. WARREN, N.J. , June 21, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 17, 2024 , the company approved non-statutory stock options to purchase an aggregate of ...